This page shows the latest Syros Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
Option, collaboration. 1, 063. Syros Pharmaceuticals/ Incyte. Gene control platform to identify up to seven therapeutic targets with a focus in myeloproliferative neoplasms. ... Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Stéphane Bancel also has experience at bioMérieux and Lilly. The founding CEO of Moderna Therapeutics, Stéphane Bancel, has joined the board of Syros Pharmaceuticals. ... Syros, which focuses on controlling a person's genes to treat cancer and other
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
No results were found
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...